Global Intraoperative Radiation Therapy Market is valued approximately USD 45.1 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 6.4 % over the forecast period 2020-2027. Intraoperative radiation therapy (IORT) is a treatment for cancer, an effective dose of radiation to tumor/tumor bed with minimal exposure to surrounding healthy tissues compared. The rising number of cancer patients as well as technological advancements in Intraoperative Radiation Therapy are the few factors responsible for growth of the market over the forecast period. For instance: according to the International Agency for Research on Cancer (IARC), in 2018, there were around 17.0 million new cancer cases and 9.5 million cancer deaths registered throughout the world. Also, the global burden of cancer is expected to grow to almost 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. Also, as per American Cancer Society conducted in 2016-17, it is estimated that approximately 75% cancer patients received chemotherapy experiencing mental impairments during treatment. Also, as per Central Bureau Tumour Registry of the United States (CBTRUS), it is estimated 16,830 deaths will be attributed to primary malignant brain and other CNS (Central Nervous System) tumors in the U.S. in 2018 with 9,490 of these deaths occurring in males and 7,340 occurring in females., Whereas, dearth of trained personnel and strong market positioning of alternative therapies are the major factor restraining the growth of the global Intraoperative Radiation Therapy market during the forecast period.
The regional analysis of global Intraoperative Radiation Therapy market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world owing to the easy availability and high adoption of IORT for cancer treatment, the rising incidence of cancer, and significant per capita annual healthcare expenditure in the US and Canada. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.
Major market player included in this report are:
Eckert & Ziegler
Ariane Medical Systems Ltd.
Becton, Dickinson And Company
Gmv Innovating Solutions
IntraOp Medical, Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
by Product & Services:
Applicators & After loaders
Treatment Planning Systems
Head & Neck Cancer
Endometrial & Cervical Cancer
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Intraoperative Radiation Therapy Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Value-Added Resellers (VARs)
Third-party knowledge providers